- Home
- SIEB vs CRVO Comparison
SIEB vs CRVO Comparison
Compare SIEB & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIEB
- CRVO
- Stock Information
- Founded
- SIEB 1886
- CRVO 2001
- Country
- SIEB United States
- CRVO United States
- Employees
- SIEB N/A
- CRVO N/A
- Industry
- SIEB Investment Bankers/Brokers/Service
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- SIEB Finance
- CRVO Health Care
- Exchange
- SIEB Nasdaq
- CRVO Nasdaq
- Market Cap
- SIEB 94.9M
- CRVO 98.3M
- IPO Year
- SIEB N/A
- CRVO N/A
- Fundamental
- Price
- SIEB $2.82
- CRVO $2.26
- Analyst Decision
- SIEB
- CRVO Buy
- Analyst Count
- SIEB 0
- CRVO 8
- Target Price
- SIEB N/A
- CRVO $38.75
- AVG Volume (30 Days)
- SIEB 15.1K
- CRVO 161.1K
- Earning Date
- SIEB 11-12-2024
- CRVO 11-12-2024
- Dividend Yield
- SIEB N/A
- CRVO N/A
- EPS Growth
- SIEB 61.43
- CRVO N/A
- EPS
- SIEB 0.27
- CRVO N/A
- Revenue
- SIEB $83,357,000.00
- CRVO $10,066,550.00
- Revenue This Year
- SIEB N/A
- CRVO $34.17
- Revenue Next Year
- SIEB N/A
- CRVO N/A
- P/E Ratio
- SIEB $10.59
- CRVO N/A
- Revenue Growth
- SIEB 27.81
- CRVO 116.29
- 52 Week Low
- SIEB $1.41
- CRVO $1.80
- 52 Week High
- SIEB $3.34
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- SIEB 42.28
- CRVO 34.18
- Support Level
- SIEB $2.86
- CRVO $2.15
- Resistance Level
- SIEB $3.14
- CRVO $2.38
- Average True Range (ATR)
- SIEB 0.12
- CRVO 0.13
- MACD
- SIEB -0.02
- CRVO 0.22
- Stochastic Oscillator
- SIEB 23.68
- CRVO 71.05
About SIEB Siebert Financial Corp.
Siebert Financial Corp is a holding company. It conducts retail discount brokerage business through its wholly-owned subsidiary. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.